Heptapeptide comes up often in conversation and rarely with the context attached. Here we lay out the basics in order, then work through the practical considerations.
Last reviewed on 2026-08-01. Where a claim depends on a specific study, the study is described rather than over-claimed.
Melanotan II is a synthetic cyclic heptapeptide analogue of alpha-melanocyte-stimulating hormone, a naturally occurring peptide involved in pigmentation signalling. Its structure substitutes a lactam bridge between side chains to increase stability relative to the native hormone. The compound is also known by the shorthand MT-II and by several non-proprietary synonyms used in research catalogues. It is not an approved therapeutic product in any major jurisdiction; material sold under this name is typically offered as a laboratory reagent rather than as a medicine.
Activity is attributed to agonism at melanocortin receptors, particularly MC1R and MC4R. Activation of MC1R on melanocytes increases melanin synthesis, which underlies the reported tanning effect. MC4R engagement in the central nervous system is linked to appetite suppression and to effects on sexual arousal reported in early clinical studies. Those studies were small and were not designed to establish efficacy or long-term safety. Receptor selectivity among the melanocortin subtypes is not absolute, which complicates attribution of any effect to a single pathway.
Regulatory treatment varies between countries. Several national medicines agencies have classified the peptide as unapproved, and customs authorities in some jurisdictions seize shipments on that basis. A few jurisdictions channel supply through prescription-only frameworks that do not list the substance by name. Because the material circulates mainly through online vendors, composition and purity are rarely verified before sale. Surveys of unapproved peptide products have reported labels that did not match measured content in a substantial fraction of samples.
Regulatory treatment of this peptide varies by country. It holds no marketing authorization as a medicine in the United States, the European Union, or most other jurisdictions. Some countries classify products containing it as prescription-only or unlicensed medicines, which restricts lawful supply. Authorities have issued public notices warning that unregulated products may contain undeclared or incorrect ingredients. The molecule also appears on prohibited lists for competitive sport. These measures address supply oversight rather than any approved therapeutic role.
Published research on the compound remains limited. Much of the human data comes from small, early-stage studies rather than large controlled trials, and several questions about effects and variability between individuals remain open. Investigators have examined receptor activity, pigment pathways, and related physiological responses in laboratory and animal models. Findings from those models do not automatically translate to human outcomes. Reviews frequently note the scarcity of rigorous clinical evidence and call for better-characterized study material.
Because the substance circulates mainly through informal markets, verification is a recurring theme in technical discussion. Independent analyses have found that labeled content and actual content can diverge, and that purity varies between samples. Analytical laboratories use reversed-phase chromatography to separate components and mass spectrometry to confirm identity. Isotope-labeled internal standards improve quantification in complex matrices. Such methods describe what a sample contains but say nothing about its sterility, lawful status, or suitability for any use. Open questions remain about how consistently testing is applied across the supply chain.
| Property | Value | Notes |
|---|---|---|
| Chemical class | Synthetic cyclic heptapeptide | Analogue of alpha-melanocyte-stimulating hormone |
| Common synonyms | MT-II; melanotan 2 | No internationally accepted non-proprietary name |
| Typical presentation | Lyophilised powder in a sealed vial | Often supplied alongside a separate diluent |
| Regulatory status | Unapproved therapeutic substance | Customs seizure reported in several jurisdictions |
| Reported route in use | Subcutaneous injection | Self-administered outside clinical settings |
Melanotan-2, also written Melanotan II, is a synthetic cyclic heptapeptide designed as an analogue of alpha-melanocyte-stimulating hormone. Its sequence is Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-NH2, and the lactam bridge between the aspartate and lysine side chains constrains the peptide into a ring. This structural change increases receptor affinity and metabolic stability relative to the native hormone. The compound was created in the 1980s as a research tool for studying pigmentation biology.
Melanocytes are the pigment-producing cells of the skin, and they carry melanocortin-1 receptors on their surface. When the receptor is activated, cyclic adenosine monophosphate rises inside the cell and raises the activity of enzymes such as tyrosinase, which increases melanin output. Melanotan-2 binds melanocortin-1 receptors in vitro and in animal models, and this binding is generally described as the basis for the tanning effect. Other receptors account for different effects: melanocortin-4 receptors contribute to appetite and erectile signalling, while melanocortin-3 and melanocortin-5 receptors contribute to energy balance and exocrine function.
Quality assessment of research-grade peptide rests mainly on reversed-phase high-performance liquid chromatography for purity and on mass spectrometry for identity confirmation. A single main peak above a stated threshold, commonly ninety-eight percent by peak area, is the usual release criterion applied by suppliers. Independent analyses commissioned by laboratories and consumer organisations have repeatedly reported discrepancies between label claims and measured content, including truncated sequences, residual trifluoroacetate, and lower-than-declared peptide mass. Those findings do not establish that every supplier is unreliable, but they indicate that purity figures printed on a vial are claims requiring verification rather than settled facts.
Regulatory treatment varies by jurisdiction and has changed over time. In several countries the peptide is handled as an unapproved prescription medicine, and import or sale for human use is restricted, while elsewhere it falls under poisons or controlled-substance schedules. Enforcement activity against online vendors has been reported in Australia, New Zealand, the United Kingdom and the United States. Scholarly writing discusses melanotan-2 chiefly as an experimental tool and as a case study in unregulated peptide supply, and its precise legal position in any given country should be checked against current national schedules.
== Books == Autobiography Not Bad for a Human – The Life and Films of Lance Henriksen – Lance Henriksen with co-author Joseph Maddrey, published in 2011 by Bloody Pulp Books, featuring art by Bill Sienkiewicz, Mike Mignola, Tom Mandrake, Tim Bradstreet, Eric Powell and Ashley Wood. Comic books To Hell You Ride (five-issue comic book from Dark Horse Comics) (2012) – Lance Henriksen and Joseph Maddrey (co-authors) with Tom Mandrake (artist); a motion-comic video was also made by Dark Horse Comics) (2012) – Lance Henriksen and Joseph Maddrey (co-authors), Tom Mandrake (artist), Lance Henriksen (narrator), TKU: Tecamachalco Underground (Cesar Gallegos/Mateo Latosa) (musical score)
=== Drug Delivery === Microbubbles can serve as drug delivery vehicles in a variety of methods. The most notable of these include: (1) incorporating a lipophilic drug to the lipid monolayer, (2) attaching nanoparticles and liposomes to the microbubble surface, (3) enveloping the microbubble within a larger liposome, and (4) electrostatically bonding nucleic acids to the microbubble surface.
== See also == Best practice, a method or technique that has been generally accepted as superior to alternatives because it tends to produce superior results European Medicines Agency (EMA), European Union agency evaluating and supervising pharmaceutical products Food and Drug Administration (FDA), a United States Food federal agency protecting and promoting public health through the control and supervision International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH), initiative to bring together regulatory authorities and pharmaceutical industry Organisation for Economic Co-operation and Development (OECD), intergovernmental organisation for stimulating economic progress and world trade through democracy, market economy, and good practices Pride of workmanship, sense of having done good work, an element of job satisfaction Validation (drug manufacture), a documented process to ensure a product meets its required specifications and quality
Sources: en.wikipedia.org
=== Measurement in body fluids === Fluoxetine and norfluoxetine may be quantitated in blood, plasma, or serum to monitor therapy, confirm a diagnosis of poisoning in hospitalized persons, or assist in a medicolegal death investigation. Blood or plasma fluoxetine concentrations are usually in a range of 50–500 μg/L in persons taking the drug for its antidepressant effects, 900–3000 μg/L in survivors of acute overdosage, and 1000–7000 μg/L in victims of fatal overdosage. Norfluoxetine concentrations are approximately equal to those of the parent drug during chronic therapy but may be substantially less following acute overdosage since it requires at least 1–2 weeks for the metabolite to achieve equilibrium.
Tividenofusp alfa, sold under the brand name Avlayah, is an enzyme replacement therapy used for the treatment of Hunter syndrome. Tividenofusp alfa is a hydrolytic lysosomal glycosaminoglycan-specific enzyme. The most common side effects include upper respiratory tract infection, ear infection, fever, anemia, cough, vomiting, diarrhea, rash, COVID-19, runny nose, nasal congestion, fall, headache, skin abrasion, and hives. Tividenofusp alfa was approved for medical use in the United States in March 2026.
2019: Micheal Anak Garing, a Malaysian hanged on 22 March 2019 for the murder of a construction worker during a series of armed robberies in 2010. 2025: Iskandar bin Rahmat, a former police officer hanged on 5 February 2025 for the 2013 Kovan double murders. 2025: Eric Teo Ghim Heng, a former property agent hanged on 16 April 2025 for the murder of his wife and their daughter in 2017, which became known as the Woodlands double murders.
Sources: en.wikipedia.org
== History == India is one of the largest producers of agricultural products and one of the global leaders in the pharmaceutical sector. Yet, it is known to have a fledgling cold-chain, which results in supply chain losses of food and other resources. These losses have been stated to be as high as USD 8 to 15 billion per annum from the agriculture sector alone. To address this concern, the government had earlier constituted a National Task Force on Cold-chain in 2008. This task force was discharged in 2010 on completing its mandate and in its report recommended that a dedicated institute be established to promote and coordinate various cold-chain initiatives undertaken by different government arms and the private industry. Cold chains are common in the food and pharmaceutical industries and also some chemical shipments. The Government of India is one of the driving forces in developing the cold-chain industry and supports private participation through various subsidy schemes and grants. Investment in cold-chain in India was also opened under the automatic route for 100% FDI participation. The existing cold-chain in India largely comprised (in 2010) of comparatively small private companies with a regional or local footprint. Most of the earlier infrastructure developed to service the cold-chain needs of the country was focused on the storage of potato.
==== T ==== Tarhana – is a Central Asian dried soup. Instant tea is a powdered mix in which water is added, in order to reconstitute it into a cup of tea. Tempeh – is soybeans pressed into a cake that undergoes fermentation. When dried it has a shelf life of several months. Terasi (trassi in Dutch) – Indonesian (especially Javanese cuisine) variant of dried shrimp paste usually pressed into dry blocks. It is also sometimes sold ground as a granulated powder.
==== Biological ==== Most birds, reptiles, insects (such as bees), and a few mammals such as mice, reindeer, dogs, and cats can see near-ultraviolet wavelengths. Many fruits, flowers, and seeds stand out more strongly from the background in ultraviolet wavelengths as compared to human color vision. Scorpions glow or take on a yellow to green color under UV illumination, thus assisting in the control of these arachnids. Mantis Shrimp such as Neogonodactylus oerstedii can sense ultraviolet wavelengths assisting them in hunting and survival. Many birds have patterns in their plumage that are invisible at usual wavelengths but observable in ultraviolet, and the urine and other secretions of some animals, including dogs, cats, and human beings, are much easier to spot with ultraviolet. Urine trails of rodents can be detected by pest control technicians for proper treatment of infested dwellings. Butterflies use ultraviolet as a communication system for sex recognition and mating behavior. For example, in the Colias eurytheme butterfly, males rely on visual cues to locate and identify females. Instead of using chemical stimuli to find mates, males are attracted to the ultraviolet-reflecting color of female hind wings. In Pieris napi butterflies it was shown that females in northern Finland with less UV-radiation present in the environment possessed stronger UV signals to attract their males than those occurring further south.
Grave fields are one of the chief sources of information on prehistoric cultures, and numerous archaeological cultures are labelled and defined by their burial customs, such as the Urnfield culture of the European Bronze Age.
Sources: en.wikipedia.org
No. No major regulatory agency has granted a marketing authorisation for melanotan II as a medicine. Products sold under this name are generally presented as laboratory reagents and are not subject to the batch-release testing applied to approved drugs.
It was developed in the 1980s by researchers investigating analogues of alpha-melanocyte-stimulating hormone for pigmentation and related endpoints. Early work included small human studies during the 1990s. Development did not progress to licensing, and the compound remained a research and grey-market item.
Peptides are prone to truncation, oxidation and aggregation during synthesis and handling. Without independent testing, a buyer cannot confirm the identity or the content of a vial. Analytical surveys of unapproved peptide products have repeatedly found discrepancies between label claims and measured composition.
Only a small number of early-stage human studies have been reported, and most were limited in size and duration. No large late-stage program has established a general efficacy or safety profile. The evidence base is therefore thin compared with approved medicines.